蚊媒疾病市場：依疾病類型、治療類型、最終使用者、地區

全球蚊媒疾病市場規模預計將從 2023 年的 31.1 億美元增至 2030 年的 51 億美元，預測期內年複合成長率為 7.3%。

圖 1. 2023 年按地區分類的蚊媒疾病全球市場佔有率(%)

蚊媒疾病是世界多個地區的重大公共衛生問題。這些疾病透過受感染的蚊子叮咬傳播，威脅人類生命並造成重大疾病負擔。對抗蚊媒疾病的創新解決方案是開發驅蚊石板。這種石板可以有效阻擋蚊子，降低瘧疾、登革熱和茲卡病毒等疾病的風險。

市場動態：

由於蚊媒疾病的盛行率不斷上升以及人們對其對公共衛生影響的認知不斷增強，預計全球蚊媒疾病市場在不久的將來將出現顯著成長。政府和醫療機構大力投資研發，以開發有效的診斷和治療方法。殺蟲劑和捕蚊器等滅蚊方法的技術進步進一步促進了市場的成長。然而，也存在一些需要解決的挑戰。市場成長的主要抑制因素之一是缺乏對醫療保健設施的認知和使用機會，特別是在新興國家。有限的衛生基礎設施、資金不足和衛生條件不佳導致了蚊媒疾病的傳播。此外，蚊子抗藥性的開拓和疫苗開發的複雜性為市場帶來了重大挑戰。

儘管有這些挑戰，全球蚊媒疾病市場仍存在巨大機會。新診斷工具、治療方法和疫苗的開發提供了潛在的成長前景。此外，製藥公司、研究機構和政府之間的合作和夥伴關係可能會加速蚊子控制和預防創新解決方案的開發。

本研究的主要特點

• 本報告對全球蚊媒疾病市場進行了詳細分析，並提供了以2022年為基準年的預測期（2023-2030年）的市場規模和年複合成長率（CAGR%）。
• 它還揭示了各個細分市場的潛在商機，並為該市場說明了一系列有吸引力的投資提案。
• 它還提供了有關市場促進因素、抑制因素、機會、新產品發布和核准、市場趨勢、區域前景、主要企業採取的競爭策略等的重要考察。
• 根據公司亮點、產品系列、主要亮點、績效和策略等參數對全球蚊媒疾病市場的主要企業進行了分析。
• 該報告的見解使行銷人員和公司負責人能夠就未來的產品發布、升級、市場擴張和行銷策略做出資訊的決策。
• 全球蚊媒疾病市場報告迎合了該行業的各種相關人員，如投資者、供應商、產品製造商、經銷商、新進業者和財務分析家。
• 透過用於分析全球蚊媒疾病市場的各種策略矩陣，將促進相關人員的決策。

目錄

第1章 研究目的與假設

• 研究目標
• 假設
• 簡稱

第2章 市場展望

• 報告說明
  • 市場定義和範圍
• 執行摘要
• Coherent Opportunity Map（COM）

第3章市場動態、法規及趨勢分析

• 市場動態
• 影響分析
• 主要亮點
• 監管場景
• 產品發布/核准
• PEST分析
• 波特的分析
• 併購場景

第4章全球蚊媒疾病市場 -冠狀病毒(COVID-19) 大流行的影響

• 新型冠狀病毒感染疾病（COVID-19）的流行病學
• 供需面分析
• 經濟影響

第5章全球蚊媒疾病市場，依疾病類型，2018-2030

• 介紹
• 瘧疾
• 登革熱
• 發燒
• 西尼羅病毒
• 基孔肯雅熱
• 茲卡病毒
• 其他

第6章 全球蚊媒疾病市場，依治療類型，2018-2030 年

• 介紹
• 劑量
• 疫苗接種
• 向量控制方式
• 免疫療法
• 支持性護理
• 其他

第 7 章 全球蚊媒疾病市場，依最終使用者分類，2018-2030 年

• 介紹
• 醫院
• 診所
• 診斷中心
• 研究機構
• 政府機關
• NGO
• 其他

第8章全球蚊媒疾病市場（按地區），2018-2030

• 介紹
• 北美洲
• 美國
• 加拿大
• 歐洲
• 德國
• 英國
• 西班牙
• 法國
• 義大利
• 俄羅斯
• 歐洲其他地區
• 亞太地區
• 中國
• 印度
• 日本
• 澳洲
• 韓國
• 東南亞國協
• 其他亞太地區
• 拉丁美洲
• 巴西
• 阿根廷
• 墨西哥
• 其他拉丁美洲
• 中東
• 海灣合作理事會國家
• 以色列
• 其他中東地區
• 非洲
• 南非
• 北非
• 中部非洲

第9章競爭形勢

• GlaxoSmithKline plc
• Sanofi SA
• Pfizer Inc.
• Merck & Co., Inc.
• Novartis AG
• Johnson & Johnson
• Eisai Co., Ltd
• Takeda Pharmaceutical Company Limited
• AstraZeneca
• Valeant Pharmaceuticals International, Inc.
• Mitsubishi Tanabe Pharma Corporation
• Abbott
• Hoffmann-La Roche Ltd
• Sun Pharmaceutical Industries Ltd
• Lupin Pharmaceuticals, Inc.
• BioCryst Pharmaceuticals, Inc.
• Mallinckrodt Pharmaceuticals
• Serum Institute of India Pvt. Ltd.
• CSL Limited
• Teva Pharmaceutical Industries Ltd

第10章

• 調查方法
• 關於出版商

Global mosquito borne disease market size is expected to reach US$ 5.10 Bn by 2030, from US$ 3.11 Bn in 2023, exhibiting a CAGR of 7.3% during the forecast period.

Figure 1. Global Mosquito Borne Disease Market Share (%), By Region, 2023

Mosquito borne disease have been a significant public health concern in several parts of the world. These diseases, transmitted through the bite of infected mosquitoes, pose a threat to human lives, and are responsible for a considerable disease burden. One innovative solution to combat mosquito borne diseases is the development of a stone slab that repels mosquitoes, and thus, offering protection to individuals. This stone slab acts as an effective barrier against mosquitoes, reducing the risk of diseases such as malaria, dengue fever, and Zika virus.

Market Dynamics:

Global mosquito borne disease market is expected to witness significant growth in the near future due to increasing incidence of mosquito-borne diseases, coupled with growing awareness about their impact on public health. Governments and healthcare organizations are investing heavily in research and development to develop effective diagnostics and treatment options. Technological advancements in mosquito control methods such as insecticides and mosquito traps are further contributing to market growth. However, there are also several challenges that need to be addressed. One of the major restraints for the market growth is the lack of awareness and access to healthcare facilities, particularly in developing countries. Limited healthcare infrastructure, inadequate funding, and poor sanitation contribute to the spread of mosquito-borne diseases. Furthermore, the development of drug resistance in mosquitoes and the complexity of vaccine development pose significant challenges to the market.

Despite these challenges, there are significant opportunities in the global mosquito borne disease market. The development of new diagnostic tools, therapeutic drugs, and vaccines offers potential growth prospects. Moreover, collaborations and partnerships between pharmaceutical companies, research institutions, and governments are likely to accelerate the development of innovative solutions for mosquito control and prevention.

Key features of the study:

• This report provides in-depth analysis of the global mosquito borne disease market, and provides market size (US$ Bn) and compound annual growth rate (CAGR%) for the forecast period (2023-2030), considering 2022 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global mosquito borne disease market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include GlaxoSmithKline plc, Sanofi S.A., Pfizer Inc., Merck & Co., Inc., Novartis AG, Johnson & Johnson, Eisai Co., Ltd, Takeda Pharmaceutical Company Limited, AstraZeneca, Valeant Pharmaceuticals International, Inc., Mitsubishi Tanabe Pharma Corporation, Abbott , F. Hoffmann-La Roche Ltd, Sun Pharmaceutical Industries Ltd, Lupin Pharmaceuticals, Inc., BioCryst Pharmaceuticals, Inc., Mallinckrodt Pharmaceuticals, Serum Institute of India Pvt. Ltd., CSL Limited, and Teva Pharmaceutical Industries Ltd
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• Global mosquito borne disease market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global mosquito borne disease market

Global Mosquito Borne Disease Market Detailed Segmentation:

• By Disease Type
  • Malaria
  • Dengue
  • Yellow Fever
  • West Nile Virus
  • Chikungunya
  • Zika Virus
  • Others
• By Treatment Type
  • Medication
  • Vaccination
  • Vector Control Methods
  • Immunotherapy
  • Supportive Care
  • Others
• By End User
  • Hospitals
  • Clinics
  • Diagnostic Centers
  • Research Institutes
  • Government Organizations
  • NGOs
  • Others
• By Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East
  • Africa
• Key Players:
  • GlaxoSmithKline plc
  • Sanofi S.A.
  • Pfizer Inc.
  • Merck & Co., Inc.
  • Novartis AG
  • Johnson & Johnson
  • Eisai Co., Ltd
  • Takeda Pharmaceutical Company Limited
  • AstraZeneca
  • Valeant Pharmaceuticals International, Inc.
  • Mitsubishi Tanabe Pharma Corporation
  • Abbott
  • Hoffmann-La Roche Ltd
  • Sun Pharmaceutical Industries Ltd
  • Lupin Pharmaceuticals, Inc.
  • BioCryst Pharmaceuticals, Inc.
  • Mallinckrodt Pharmaceuticals
  • Serum Institute of India Pvt. Ltd.
  • CSL Limited
  • Teva Pharmaceutical Industries Ltd

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Mosquito Borne Disease, By Disease Type
  • Market Mosquito Borne Disease, By Treatment Type
  • Market Mosquito Borne Disease, By End User
  • Market Mosquito Borne Disease, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
• Impact Analysis
• Key Highlights
• Regulatory Scenario
• Product Launches/Approvals
• PEST Analysis
• PORTER's Analysis
• Merger and Acquisition Scenario

4. Global Mosquito Borne Disease Market - Impact of Coronavirus (COVID-19) Pandemic

• COVID-19 Epidemiology
• Supply Side and Demand Side Analysis
• Economic Impact

5. Global Mosquito Borne Disease Market, By Disease Type, 2018-2030, (US$ Bn)

• Introduction
  • Market Share Analysis, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, 2019 - 2030
  • Segment Trends
• Malaria
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
• Dengue
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
• Yellow Fever
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
• West Nile Virus
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
• Chikungunya
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
• Zika Virus
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)

6. Global Mosquito Borne Disease Market, By Treatment Type, 2018-2030, (US$ Bn)

• Introduction
  • Market Share Analysis, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, 2019 - 2030
  • Segment Trends
• Medication
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
• Vaccination
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
• Vector Control Methods
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bin)
• Immunotherapy
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
• Supportive Care
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)

7. Global Mosquito Borne Disease Market, By End User, 2018-2030, (US$ Bn)

• Introduction
  • Market Share Analysis, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, 2019 - 2030
  • Segment Trends
• Hospitals
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
• Clinics
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
• Diagnostic Centers
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
• Research Institutes
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
• Government Organizations
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
• NGOs
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)

8. Global Mosquito Borne Disease Market, By Region, 2018-2030, (US$ Bn)

• Introduction
  • Market Share Analysis, By Region, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, For Region, 2019 -2030
  • Country Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2018-2030, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2018-2030, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
• U.S.
• Canada
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2018-2030, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2018-2030, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
• Germany
• U.K.
• Spain
• France
• Italy
• Russia
• Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2018-2030, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2018-2030, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
• China
• India
• Japan
• Australia
• South Korea
• ASEAN
• Rest of Asia Pacific
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2018-2030, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2018-2030, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
• Brazil
• Argentina
• Mexico
• Rest of Latin America
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2018-2030, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2018-2030, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
• GCC Countries
• Israel
• Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2018-2030, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2018-2030, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2018-2030, (US$ Bn)
• South Africa
• North Africa
• Central Africa

9. Competitive Landscape

• GlaxoSmithKline plc
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Sanofi S.A.
• Pfizer Inc.
• Merck & Co., Inc.
• Novartis AG
• Johnson & Johnson
• Eisai Co., Ltd
• Takeda Pharmaceutical Company Limited
• AstraZeneca
• Valeant Pharmaceuticals International, Inc.
• Mitsubishi Tanabe Pharma Corporation
• Abbott
• Hoffmann-La Roche Ltd
• Sun Pharmaceutical Industries Ltd
• Lupin Pharmaceuticals, Inc.
• BioCryst Pharmaceuticals, Inc.
• Mallinckrodt Pharmaceuticals
• Serum Institute of India Pvt. Ltd.
• CSL Limited
• Teva Pharmaceutical Industries Ltd
• Analyst Views

10. Section

• Research Methodology
• About us